White House pulls the plug on proposed drug-rebate overhaul, CVS stock ticks up

THE WHITE HOUSE abandoned a push to end rebates paid to middlemen who negotiate drug prices on behalf of health insurers. CVS Health Corp.'s stock jumped up to 7% Thursday following the announcement. / BLOOMBERG NEWS FILE PHOTO/SIMON DAWSON
THE WHITE HOUSE abandoned a push to end rebates paid to middlemen who negotiate drug prices on behalf of health insurers. CVS Health Corp.'s stock jumped up to 7% Thursday following the announcement. / BLOOMBERG NEWS FILE PHOTO/SIMON DAWSON
WASHINGTON – The White House abandoned a push to end rebates paid to middlemen who negotiate drug prices on behalf of health insurers, a move that could turn scrutiny back on how drugmakers themselves set prices. President Donald Trump has made lowering prescription-drug costs a top priority of his administration, and ending rebates was seen…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -